GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuyu Pharma Inc (XKRX:000220) » Definitions » EV-to-Revenue

Yuyu Pharma (XKRX:000220) EV-to-Revenue : 0.65 (As of Jun. 08, 2024)


View and export this data going back to 1975. Start your Free Trial

What is Yuyu Pharma EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Yuyu Pharma's enterprise value is ₩89,124 Mil. Yuyu Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩136,320 Mil. Therefore, Yuyu Pharma's EV-to-Revenue for today is 0.65.

The historical rank and industry rank for Yuyu Pharma's EV-to-Revenue or its related term are showing as below:

XKRX:000220' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.48   Med: 0.86   Max: 2.67
Current: 0.65

During the past 13 years, the highest EV-to-Revenue of Yuyu Pharma was 2.67. The lowest was 0.48. And the median was 0.86.

XKRX:000220's EV-to-Revenue is ranked better than
87.94% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 2.275 vs XKRX:000220: 0.65

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-08), Yuyu Pharma's stock price is ₩4840.00. Yuyu Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩8,441.07. Therefore, Yuyu Pharma's PS Ratio for today is 0.57.


Yuyu Pharma EV-to-Revenue Historical Data

The historical data trend for Yuyu Pharma's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuyu Pharma EV-to-Revenue Chart

Yuyu Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.77 1.14 1.09 0.86 0.75

Yuyu Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.81 0.79 0.75 0.74

Competitive Comparison of Yuyu Pharma's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Yuyu Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yuyu Pharma's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yuyu Pharma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Yuyu Pharma's EV-to-Revenue falls into.



Yuyu Pharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Yuyu Pharma's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=89124.444/136320.344
=0.65

Yuyu Pharma's current Enterprise Value is ₩89,124 Mil.
Yuyu Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩136,320 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yuyu Pharma  (XKRX:000220) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Yuyu Pharma's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4840.00/8441.066
=0.57

Yuyu Pharma's share price for today is ₩4840.00.
Yuyu Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8,441.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yuyu Pharma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Yuyu Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Yuyu Pharma (XKRX:000220) Business Description

Traded in Other Exchanges
Address
197, Dongho-ro, Yuyu Building, Jung-gu, Seoul, KOR
Yuyu Pharma Inc. manufactures and markets medicines. The major product is the medicines for Alzheimer's, which accounts for 45% of total revenue. The company also engages in health aid foods, rental of oxygen generator and analysis of medicines.

Yuyu Pharma (XKRX:000220) Headlines

No Headlines